Fostamatinib
Last Updated: 09/19/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 398 publications
Emerging synthetic drugs for the management of hidradenitis suppurativa: a comprehensive update.
Journal: Expert opinion on pharmacotherapy
Published: June 24, 2026
Nasal Mucosal Necrosis in a Patient with Systemic Lupus Erythematosus and Antiphospholipid Syndrome: A Case Report and Literature Review.
Journal: Journal of clinical medicine
Published: June 23, 2026
Impact of Fostamatinib on Inflammatory Biomarkers in Hospitalized Patients With COVID-19.
Journal: Critical care explorations
Published: June 22, 2026
Aging-driven transcriptional programs in diabetic kidney disease: multi-omics discovery of diagnostic biomarkers and drug-repurposing targets.
Journal: Clinical epigenetics
Published: June 17, 2026
Early Use of Fostamatinib in Immune Thrombocytopenia.
Journal: Advances in therapy
Published: June 02, 2026
Transcriptomic Profiling and Drug Repurposing Identify Fostamatinib as a Candidate Therapeutic Agent for IgG4-Related Sialadenitis.
Journal: Modern rheumatology
Published: May 27, 2026
A phase I open label study of fostamatinib, a SYK inhibitor, in patients with lower-risk myelodysplastic syndrome and chronic myelomonocytic leukemia.
Journal: Leukemia & lymphoma
Published: March 30, 2026
Successful combination therapy with fostamatinib and romiplostim in refractory immune thrombocytopenia 27 years after onset
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: March 29, 2026
Real-World Experiences in the Treatment of Immune Thrombocytopenia over a 2-Year Period.
Journal: Oncology research and treatment
Published: March 19, 2026
Identification of senescence-related genes in diagnosing idiopathic pulmonary fibrosis via integrating bioinformatics analysis and machine learning.
Journal: PloS one
Published: March 13, 2026
Post-marketing surveillance of fostamatinib for primary immune thrombocytopenia in Japan: interim analysis.
Journal: International journal of hematology
Published: March 05, 2026
Efficacy of fostamatinib add-on for TPO receptor agonist-refractory immune thrombocytopenia
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: March 04, 2026
Last Updated: 09/19/2026